Saunders E J, Saunders J A
Health Care Women Int. 1990;11(4):423-32. doi: 10.1080/07399339009515912.
A pregnant woman and the fetus she carries face health risks from many sources. One risk that requires ongoing vigilance is the use of prescription drugs during pregnancy. The international health care community has been sensitized to the risks of drug use during pregnancy because of three pharmaceuticals that have caused widespread crises for mothers and their offspring. The crises that diethylstilbestrol, thalidomide, and, to a lesser extent, Bendectin have created in the past four decades are reviewed in this article. The lessons these drug crises can teach us are articulated in the belief that similar crises may be averted in the future.
孕妇及其腹中胎儿面临着诸多健康风险。其中一项需要持续警惕的风险便是孕期使用处方药。由于三种药物曾给母亲及其后代造成广泛危机，国际医疗界已开始关注孕期用药的风险。本文将回顾己烯雌酚、沙利度胺以及（程度稍轻的）苯海拉明在过去四十年间引发的危机。我们坚信，从这些药物危机中吸取的教训能够让我们避免未来可能出现的类似危机。
